Foundry Partners’s AtriCure ATRC Stock Holding History

Foundry Partners’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-31,644	Closed	-$2.07M	–	375
2021 Q1	$2.07M	Sell	31,644 -14,547	-31%	-$896K	0.07%	271
2020 Q4	$2.57M	Sell	46,191 -217	-0.5%	-$9.38K	0.1%	246
2020 Q3	$1.85M	Buy	46,408 +7,828	+20%	+$332K	0.09%	260
2020 Q2	$1.73M	Sell	38,580 -1,485	-4%	-$64.7K	0.08%	257
2020 Q1	$1.35M	Buy	+40,065	New	+$1.44M	0.08%	271

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Foundry Partners's ATRC Position: Q2 2021 in Review

Foundry Partners sold out of AtriCure (ATRC) in Q2 2021, closing a stake of 31,644 shares — an estimated $2.07M sold.

Foundry Partners first reported a position in ATRC in Q1 2020 and held it in 5 quarters. The position peaked at $2.57M in Q4 2020. 212 funds tracked by Wall St. Rank hold ATRC as of Q2 2021.

Foundry Partners reported no remaining AtriCure position as of Q2 2021 after selling out during the quarter.
Foundry Partners sold 31,644 AtriCure shares in Q2 2021, an estimated $2.07M.
Foundry Partners first reported a position in AtriCure in Q1 2020 and held it in 5 quarters.
Foundry Partners's AtriCure position peaked at $2.57M in Q4 2020.
212 funds tracked by Wall St. Rank held AtriCure as of Q2 2021.

Based on Foundry Partners's 13F filing for Q2 2021, filed 23 Jul 2021.